Lead antibody MB0109 targets C1q and uniquely inhibits both classical complement cascade and C1q-mediated macrophage/microglial activation — two key drivers of neuroinflammationMB0109 demonstrated ...
Thank you, Eva, and thank you all for joining us this morning. Before turning to our fourth quarter results, I would like to ...
Spinal cord injury often triggers a cascade of secondary damage that severely limits functional recovery, largely driven by ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
The UPV participates in HIVision Spain, a national HIV simulator designed to support health policy decisions to end the epidemic in Spain ...
News-Medical.Net on MSN
Spatial intelligence platform supports health policy decisions aimed at ending HIV
INCLIVA Healthcare Research Institute-University Clinical Hospital of Valencia, the Universitat Politècnica de València - ...
Explore Marie Selby Botanical Gardens in Sarasota, Florida, where 6,000 orchids, bayfront views, canopy walks, and seasonal ...
In a startling incident that has raised fresh concerns about the reliability of AI infrastructure, Amazon Web Services (AWS) — the world’s largest cloud provider — recently experienced a widespread ...
The National Interest on MSN
As America and Iran Move Toward War, Turkey Is Caught in the Middle
Few nations in the Middle East have more to lose from a broader US-Iran war than Turkey.
Tyler Van Buren here, senior biotech analyst at TD Cowen. Thank you very much for joining TD Cowen's 46th Annual Healthcare Conference. For next session or first session of the day, actually, very ...
Lithium batteries power an expanding range of technologies, from electric vehicles and commercial transportation fleets to stationary energy storage systems and grid-scale backup power installations.
Morning Overview on MSN
Could attacking toxic protein chains finally slow neurodegenerative disease?
Researchers are testing a fundamentally different strategy against neurodegenerative disease: instead of clearing protein deposits after they form, new experimental therapies aim to stop toxic protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results